Quintet Private Bank (Europe) S.A. Moderna, Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.75 Trillion
- Q3 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 55 shares of MRNA stock, worth $2,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55
Previous 732
92.49%
Holding current value
$2,050
Previous $97.7 Million
96.24%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.58 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.5 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$953 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$628 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$269 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...